- Filed
- Apr 24, 2024 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2024 · Apr 8, 2024 | 63.48M sh |
| Shares Diluted | Q3 2024 · Jan 31, 2024 | 63.32M sh |
| Shares Diluted | Q3 2024 · Jan 31, 2024 | 63.1M sh |
| Shares Diluted restated | Q3 2024 · Jan 31, 2023 | 69.16M sh |
| Shares Diluted | Q3 2024 · Jan 31, 2023 | 63.63M sh |
| Capex | Q3 2024 · Jan 31, 2024 | $26.11M |
| Capex restated | Q3 2024 · Jan 31, 2023 | $52.58M |
| Operating Cash Flow | Q3 2024 · Jan 31, 2024 | $9.7M |
| Operating Cash Flow restated | Q3 2024 · Jan 31, 2023 | −$15.87M |
| Long Term Debt | Q3 2024 · Jan 31, 2024 | $54.91M |
| Cash And Equivalents | Q3 2024 · Jan 31, 2024 | $30.71M |
| Cash And Equivalents | Q3 2024 · Apr 30, 2023 | $38.54M |
| Cash And Equivalents | Q3 2024 · Jan 31, 2023 | $59.92M |
| Cash And Equivalents | Q3 2024 · Apr 30, 2022 | $126.17M |
| Stockholders Equity | Q3 2024 · Jan 31, 2024 | $180.17M |
| Stockholders Equity | Q3 2024 · Oct 31, 2023 | $183.33M |
| Stockholders Equity | Q3 2024 · Apr 30, 2023 | $189.17M |
| Stockholders Equity restated | Q3 2024 · Jan 31, 2023 | $185.12M |
| Stockholders Equity restated | Q3 2024 · Oct 31, 2022 | $181.63M |
| Stockholders Equity | Q3 2024 · Apr 30, 2022 | $174.53M |
| Current Liabilities | Q3 2024 · Jan 31, 2024 | $222.89M |
| Current Liabilities | Q3 2024 · Apr 30, 2023 | $215.15M |
| Total Liabilities | Q3 2024 · Jan 31, 2024 | $275.06M |
| Total Liabilities | Q3 2024 · Apr 30, 2023 | $262.4M |
| Current Assets | Q3 2024 · Jan 31, 2024 | $103.59M |
| Current Assets | Q3 2024 · Apr 30, 2023 | $112.45M |
| Total Assets | Q3 2024 · Jan 31, 2024 | $455.23M |
| Total Assets | Q3 2024 · Apr 30, 2023 | $451.57M |
| Eps Diluted | Q3 2024 · Jan 31, 2024 | −$0.09 |
| Eps Diluted | Q3 2024 · Jan 31, 2024 | −$0.28 |
| Eps Diluted restated | Q3 2024 · Jan 31, 2023 | $0.00 |
| Eps Diluted | Q3 2024 · Jan 31, 2023 | $0.01 |
| Eps Basic | Q3 2024 · Jan 31, 2024 | −$0.09 |
| Eps Basic | Q3 2024 · Jan 31, 2024 | −$0.28 |
| Eps Basic restated | Q3 2024 · Jan 31, 2023 | $0.00 |
| Eps Basic | Q3 2024 · Jan 31, 2023 | $0.01 |
| Sga Expense | Q3 2024 · Jan 31, 2024 | $6.38M |
| Sga Expense | Q3 2024 · Jan 31, 2024 | $19.2M |
| Sga Expense | Q3 2024 · Jan 31, 2023 | $7.11M |
| Sga Expense | Q3 2024 · Jan 31, 2023 | $20.32M |
| Net Income | Q3 2024 · Jan 31, 2024 | −$6.01M |
| Net Income | Q3 2024 · Jan 31, 2024 | −$17.65M |
| Net Income restated | Q3 2024 · Jan 31, 2023 | −$247K |
| Net Income restated | Q3 2024 · Jan 31, 2023 | $594K |
| Operating Income | Q3 2024 · Jan 31, 2024 | −$4M |
| Operating Income | Q3 2024 · Jan 31, 2024 | −$17.38M |
| Operating Income | Q3 2024 · Jan 31, 2023 | $2.72M |
| Operating Income | Q3 2024 · Jan 31, 2023 | $2.77M |
| Gross Profit | Q3 2024 · Jan 31, 2024 | $2.38M |
| Gross Profit | Q3 2024 · Jan 31, 2024 | $1.82M |
| Gross Profit | Q3 2024 · Jan 31, 2023 | $9.83M |
| Gross Profit | Q3 2024 · Jan 31, 2023 | $23.09M |
| Revenue | Q3 2024 · Jan 31, 2024 | $33.82M |
| Revenue | Q3 2024 · Jan 31, 2024 | $96.94M |
| Revenue | Q3 2024 · Jan 31, 2023 | $38.02M |
| Revenue | Q3 2024 · Jan 31, 2023 | $109.47M |